We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Animation: How New “Trojan Horse” Antibody Strategy Kills Ebola

Video   Dec 20, 2017 | Original Video from Albert Einstein College of Medicine

 

Using animation, Dr. Kartik Chandran explains how he worked with a team of scientists to develop a new therapeutic strategy to target a hidden Achilles’ heel shared by all known types of Ebola virus. Two antibodies developed with this strategy blocked the invasion of human cells by all five ebolaviruses. The team included scientists from Albert Einstein College of Medicine, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Integrated Biotherapeutics, Vanderbilt University Medical Center, and The Scripps Research Institute.

 
More Information
 
 
 

Recommended Videos

CAR T-cell Therapy: Reprogramming the Immune System To Treat Cancer

Video

Researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.

WATCH NOW

ADDomer – A New Kind of Vaccine for Untreatable Infection

Video

Scientists from the University of Bristol, CNRS and Imophoron Ltd worked with the computer technology giant Oracle to develop a new kind of vaccine that needs no refrigeration. They used synthetic biology, cryo-electron microscopy and high-performance cloud computing to produce a candidate vaccine against the mosquito-borne chikungunya virus. Their findings could revolutionise the way vaccines are designed, developed and stored.

WATCH NOW

Biomarker-based Companion Diagnostics Are Enabling Precision Oncology

Video

Clinical trials are underway to examine the efficacy of various immune checkpoint inhibitor molecules, for the treatment of cancer. Watch this video to learn about the companion diagnostics that are enabling the identification of patients who could benefit from these treatments.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE